Moderna CMO Hints at Filing Cancer Vaccine with PII Data, Topline Readout Soon

December 8, 2022
Moderna Chief Medical Officer Paul Burton Moderna’s Chief Medical Officer Paul Burton on December 7 suggested that the company could seek approval for its mRNA-based personalized cancer vaccine being jointly developed with Merck based on mid-stage study data. The vaccine...read more